Search research articles
Contact Us
Filters
Showing results (1-10 of 123) with videos related to
Page
of 13
Sort By:
Hematology. American Society of Hematology. Education Program
|
November 25, 2006
Controversies in follicular lymphoma: "who, what, when, where, and why?" (not necessarily in that order!)
Myron S Czuczman
Journal of the National Comprehensive Cancer Network : JNCCN
|
April 11, 2013
Update: NCCN non-Hodgkin's lymphoma clinical practice guidelines
Myron S Czuczman
Seminars in Oncology
|
June 1, 2002
Immunochemotherapy in indolent non-Hodgkin's lymphoma
Myron S Czuczman
Leukemia & Lymphoma
|
October 15, 2008
Sixth International Workshop on non-Hodgkin Lymphoma: 16-17 November 2007, Boston, USA
Myron S Czuczman
Clinical Advances in Hematology & Oncology : H&O
|
April 10, 2015
Management strategies for relapsed/refractory MCL
Myron S Czuczman
Future Oncology (London, England)
|
August 10, 2011
Update on novel monoclonal antibodies and immunoconjugates for the treatment of lymphoproliferative disorders
Lyudmyla Derby, Myron S Czuczman
Clinical Lymphoma, Myeloma & Leukemia
|
July 29, 2014
Follicular lymphoma grade 3: review and updates
Gayatri Vaidyanathan, Myron S Czuczman
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
April 23, 2010
Bendamustine for the treatment of indolent non-Hodgkin's lymphoma and chronic lymphocytic leukemia
Anjana Elefante, Myron S Czuczman
Expert Opinion on Biological Therapy
|
January 23, 2010
Galiximab: a review
Seema Bhat, Myron S Czuczman
Current Opinion in Oncology
|
August 23, 2002
Radioimmunotherapy in non-Hodgkin lymphoma
Asher Chanan-Khan, Myron S Czuczman
Page
of 13
Search research articles
Search
Showing results (1-10 of 123) with videos related to
Sort By:
Page
of 13
Hematology. American Society of Hematology. Education Program
|
November 25, 2006
Controversies in follicular lymphoma: "who, what, when, where, and why?" (not necessarily in that order!)
Myron S Czuczman
Journal of the National Comprehensive Cancer Network : JNCCN
|
April 11, 2013
Update: NCCN non-Hodgkin's lymphoma clinical practice guidelines
Myron S Czuczman
Seminars in Oncology
|
June 1, 2002
Immunochemotherapy in indolent non-Hodgkin's lymphoma
Myron S Czuczman
Leukemia & Lymphoma
|
October 15, 2008
Sixth International Workshop on non-Hodgkin Lymphoma: 16-17 November 2007, Boston, USA
Myron S Czuczman
Clinical Advances in Hematology & Oncology : H&O
|
April 10, 2015
Management strategies for relapsed/refractory MCL
Myron S Czuczman
Future Oncology (London, England)
|
August 10, 2011
Update on novel monoclonal antibodies and immunoconjugates for the treatment of lymphoproliferative disorders
Lyudmyla Derby, Myron S Czuczman
Clinical Lymphoma, Myeloma & Leukemia
|
July 29, 2014
Follicular lymphoma grade 3: review and updates
Gayatri Vaidyanathan, Myron S Czuczman
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
April 23, 2010
Bendamustine for the treatment of indolent non-Hodgkin's lymphoma and chronic lymphocytic leukemia
Anjana Elefante, Myron S Czuczman
Expert Opinion on Biological Therapy
|
January 23, 2010
Galiximab: a review
Seema Bhat, Myron S Czuczman
Current Opinion in Oncology
|
August 23, 2002
Radioimmunotherapy in non-Hodgkin lymphoma
Asher Chanan-Khan, Myron S Czuczman
Page
of 13